Cutera (CUTR) Receiving Somewhat Positive Press Coverage, Study Shows

Press coverage about Cutera (NASDAQ:CUTR) has trended somewhat positive recently, Accern Sentiment reports. Accern ranks the sentiment of media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cutera earned a news sentiment score of 0.14 on Accern’s scale. Accern also gave press coverage about the medical device company an impact score of 46.2689791012075 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Cutera (NASDAQ CUTR) traded down $0.05 on Friday, reaching $44.90. 133,556 shares of the company’s stock traded hands, compared to its average volume of 176,141. The firm has a market cap of $628.83, a PE ratio of 59.87, a PEG ratio of 1.34 and a beta of 0.41. Cutera has a 52-week low of $18.50 and a 52-week high of $52.90.

Several research firms have weighed in on CUTR. BidaskClub upgraded shares of Cutera from a “hold” rating to a “buy” rating in a research report on Tuesday, December 12th. Zacks Investment Research cut shares of Cutera from a “hold” rating to a “sell” rating in a research report on Monday, January 1st. Finally, Maxim Group restated a “hold” rating on shares of Cutera in a research report on Wednesday, November 8th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. Cutera has a consensus rating of “Buy” and a consensus target price of $37.33.

In other news, Director David B. Apfelberg sold 1,000 shares of Cutera stock in a transaction that occurred on Friday, November 17th. The shares were sold at an average price of $42.55, for a total transaction of $42,550.00. Following the completion of the sale, the director now owns 8,055 shares in the company, valued at approximately $342,740.25. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Miguel Pardos sold 10,000 shares of Cutera stock in a transaction that occurred on Tuesday, December 12th. The stock was sold at an average price of $46.70, for a total transaction of $467,000.00. Following the sale, the executive vice president now owns 39,698 shares of the company’s stock, valued at approximately $1,853,896.60. The disclosure for this sale can be found here. Insiders sold a total of 26,268 shares of company stock valued at $1,202,691 in the last 90 days. Corporate insiders own 11.60% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This piece was first posted by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of US & international copyright laws. The correct version of this piece can be read at https://stocknewstimes.com/2018/02/11/cutera-cutr-receiving-somewhat-positive-press-coverage-study-shows.html.

Cutera Company Profile

Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.

Insider Buying and Selling by Quarter for Cutera (NASDAQ:CUTR)

Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply